Phosphine

Phosphine

SCHEMBL1542539

COCCl.P

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphine SCHEMBL22034376 1.00
SCHEMBL5308881 0.95
SCHEMBL717 0.95
SCHEMBL31384629 0.90
Water SCHEMBL9266583 0.90
Hydrochloric Acid SCHEMBL23297299 0.90
SCHEMBL9603484 0.90
SCHEMBL16741241 0.90
Ammonia Solution, Strong SCHEMBL28232154 0.90
Hydrogen Sulfide SCHEMBL27830769 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776404-B1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE UNIV CONNECTICUT (US) 2016-07-06 EP disclosed
US-20150344780-A1 Liquid Crystal Compound, Liquid Crystal Composition and Methods for Preparing the Same, Liquid Crystal Display Panel BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-03 US disclosed
US-9193910-B1 Liquid crystal compound, liquid crystal composition and methods for preparing the same, liquid crystal display panel BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-11-24 US disclosed
US-8853228-B2 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase UNIVERSITY OF CONNECTICUT (US) 2014-10-07 US disclosed
EP-2776404-A1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE University of Connecticut (US) 2014-09-17 EP disclosed
WO-2013070620-A1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE UNIVERSITY OF CONNECTICUT (US) 2013-05-16 WO disclosed
US-8273773-B2 Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (US) 2012-09-25 US disclosed
US-20120196859-A1 HETEROCYCLIC ANALOGS OF PROPARGYL-LINKED INHIBITORS OF DIHYDROFOLATE REDUCTASE UNIVERSITY OF CONNECTICUT 2012-08-02 US disclosed
EP-2307372-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2012-04-25 EP disclosed
EP-2307372-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2011-04-13 EP disclosed
WO-2010010017-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-01-28 WO disclosed
US-20100021423-A1 Heterocyclic antiviral compounds ROCHE PALO ALTO LLC 2010-01-28 US disclosed
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
CN-1217936-C Heterocyclic compounds having sulfonic acid EISAI CO LTD (JP) 2005-09-07 CN disclosed
CN-1414952-A Heterocyclic compounds having sulfonic acid EISAI CO LTD (JP) 2003-04-30 CN disclosed
CN-1069976-A Hexanaphthene and tetrahydropyran derivatives HOFFMANN LA ROCHE (CH) 1993-03-17 CN disclosed